Skip to main content
Caplight Logo









TheraV

TheraV

Private
Newark, DelawareHealthcare & Life Scienceshttps://www.therav.me/

Last Round

Grant

Dec 16, 2021

Total Funding Raised

$167,000

Company Overview

TheraV is a therapeutic devices company that develops wearable products using vibration technology to help amputees manage phantom limb pain.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, D2C Brands, Health IoT

Business Model

B2C

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

phantom limb painvibration therapywearable therapymedical devicedrug-free pain reliefamputee caretherapeutic apparelnon-invasive therapyneuromodulationpain managementdigital therapeuticsrehabilitation technologyD2C medical devicehealth IoT

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

TheraV Comparables

Compare TheraV with similar companies based on industry and business-model similarity.

TheraV comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Avanos Medical
61%
Lifeward Ltd.
59%
RxFunction
59%

TheraV Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantDec 16, 2021
AcceleratorSep 9, 2021
GrantJun 8, 2021
GrantMar 1, 2019
GrantJan 1, 2018

Key People

Founding team and executive leadership

Amira Idris Radović

CEO Founder

Founding Team

TheraV Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 4, 2025

    Monthly visitors increased 444% MoM, reaching 1.8K.

  • Dec 16, 2021

    $100K grant received from Delaware Division of Small Business.

TheraV Filings

Explore SEC and related filing metadata, where available.

TheraV filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about TheraV's valuation, stock price, and market status.

Is TheraV a public or private company?

TheraV is a private company.

What is the current stock price of TheraV?

TheraV is a private company with no public stock price. No recent secondary market data is available.

How much is TheraV worth (valuation)?

Valuation information for TheraV is not publicly available.

Can I buy TheraV stock?

TheraV shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was TheraV's last funding round?

TheraV's most recent funding round was Grant on December 16, 2021.

Who are the main investors in TheraV?

Key investors in TheraV include Delaware Division of Small Business, WomensNet, Startup Bucks, Horn Entrepreneurship, JPMorgan Chase & Co..

Will TheraV IPO soon?

No public IPO plans have been announced for TheraV.

How can I track TheraV secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor TheraV's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNewark, Delaware
Employee Range1
Year Founded2016
Last FundingDec 16, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?